Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides

Table 1 Protein expression for K-ras and IGF-IR on Patu8988 cells detected by flow cytometry (%)

Groups	Positive rate
	K-ras protein	IGF-IR protein
K-ras ASODN	25.95 ± 0.18b	85.25 ± 0.99
IGF-IR ASODN	69.18 ± 0.87	40.78 ± 1.42b
Combination	19.69 ± 1.15b	38.25 ± 1.22b
Control	76.15 ± 1.62	91.53 ± 1.62

All values are presented as mean ± SD of triplicate determinations.

^bP < 0.01 vs control group.